Culturally Tailored Education for Type 2 Diabetes
Trial Summary
What is the purpose of this trial?
Diabetes mellitus (DM) is a global public health concern. In the United States, adult Hispanic males are particularly vulnerable to type 2 diabetes mellitus and are more likely to develop complications and subsequently die from it, compared to non-Hispanic White males. Evidence suggests good self-management behaviors can potentially prevent disease-related complications and improve clinical outcomes. The American Diabetes Association and Association of Diabetes Care and Education Specialists have endorsed diabetes self-management education as a necessary component of care for all individuals living with the disease. However, adult Hispanic males with type 2 diabetes mellitus living in the Middle Atlantic Region of the U.S., especially those who are underserved, typically lack access to formal diabetes self-management education (DSME). Further, the majority have never participated in such educational activities (Au et al., 2021; New Jersey Department of Health, 2013; 2017; 2023). A large body of evidence suggests DSME can effectively improve self-management behaviors in diverse populations around the globe (Abraham et al., 2020; Dietz et al., 2022; ElGerges, 2020; Gehlawat et al., 2019; Hailu et al., 2019; Jiang et al., 2022; Leong et al., 2022; Oluchina, 2022; Riangkam et al., 2022; Tamiru et al., 2023; Yu et al., 2022; Zheng et al., 2019). The purpose of the proposed study is to examine the effect of culturally tailored diabetes education on self-management behaviors of adult Hispanic males, aged 18-64 years, with type 2 diabetes mellitus living in the Middle Atlantic Region of the U.S. This study can shed more light on the effectiveness of community-based, culturally tailored diabetes educational activities in this vulnerable population and guide future efforts towards enhancing self-management.
Research Team
Beryl O'Donnell, MSN, RN, NP-C
Principal Investigator
Hackensack Meridian Health
Eligibility Criteria
This trial is for adult Hispanic males aged 18-64 in the Middle Atlantic Region of the U.S. with type 2 diabetes mellitus (T2DM). Participants must speak English or Spanish and not have severe kidney disease or terminal illnesses like cancer.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Culturally Tailored Diabetes Education (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hackensack Meridian Health
Lead Sponsor
Dr. Gregory J. Rokosz
Hackensack Meridian Health
Chief Medical Officer since 2023
DO from New York College of Osteopathic Medicine, JD from Seton Hall University School of Law
Robert C. Garrett
Hackensack Meridian Health
Chief Executive Officer since 2016
Bachelor's degree in Health Administration from Washington University in St. Louis